Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery and delivery of next-generation preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make seamless, person-centered care the standard in Central Texas and beyond.
Get Care
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Moe Aung, M.D., Ph.D.

UT Health Austin Care Team Member
Education

Dual MD and PhD, Neuroscience
Emory University School of Medicine

BA, Biology
Grinnell College

Residency/Fellowship

Residency, Neurology
Hospital of the University of Pennsylvania, Philadelphia

About

Moe Hein “Harry” Aung, MD, PhD, is a board-certified neuro-ophthalmologist in UT Medicine’s Mitchel and Shannon Wong Eye Institute. He specializes in the diagnosis and treatment of a wide range of visual disorders caused by neurologic diseases, including optic nerve abnormalities (e.g., optic neuritis, ischemic optic neuropathy), visual field deficits, pupillary asymmetry, double vision, and eye movement disorders. Additionally, Dr. Aung is an assistant professor in both the Department of Ophthalmology and the Department of Neurology at the Dell Medical School at The University of Texas at Austin.


Dr. Aung earned his bachelor’s degree in biology from Grinnell College. He earned both his medical degree and his doctorate in neuroscience from Emory University School of Medicine through a dual-degree program. He completed an internship in internal medicine at Emory University. He completed both a residency in neurology and a fellowship in neuro-ophthalmology at the University of Pennsylvania.


Dr. Aung’s former research investigated the role of retinal dopamine in visual dysfunction in early-stage diabetic retinopathy. His clinical and research focus on understanding the effects of other neuro-ophthalmic disorders on the retinal dopaminergic system. He is an active member of the American Academy of Neurology and the North American Neuro-Ophthalmology Society.